| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1057 | 96 | 94 | 22 |
Current Treatment Options in Oncology was organized to reinforce research efforts on Internal medicine, Oncology, Surgery, Radiation therapy and Disease. It links adjacent topics like Internal medicine with Immunology. The Immunology works, particularly on Lymphoma are tackled in the journal.
The journal focuses on Oncology but sometimes tackles the closely related topic of Immunotherapy which is concerned with Cancer research. Surgery research presented in it encompasses a variety of subjects, including Sarcoma and General surgery. Soft tissue sarcoma is part of Sarcoma studies tackled in the journal.
Radiation therapy research is the primary subject tackled in Current Treatment Options in Oncology with a focus on Combined Modality Therapy. Most of the Disease studies addressed also intersect with Intensive care medicine. Current Treatment Options in Oncology emphasizes research on Cancer, which includes concerns such as Colorectal cancer.
The journal publications are organized to reinforce research efforts on Internal medicine, Oncology, Surgery, Radiation therapy and Disease. The journal publications explore research in Internal medicine and the adjacent study of Pathology. While the most cited articles focused on Oncology, they were also able to explore topics like Survival rate, Immunology, Targeted therapy, Breast cancer and Immunotherapy.
Current Treatment Options in Oncology focuses largely on the fields of Internal medicine, Oncology, Cancer, Clinical trial and Disease. Chemotherapy, Immunotherapy, Targeted therapy, Pembrolizumab and Radiation therapy are Internal medicine topics of special interest in it. Immune checkpoint, Regimen, Minimal residual disease, Metastasis and Breast cancer are some topics wherein Oncology research discussed in the journal have an impact.
Issues in Cancer were discussed, taking into consideration concepts from other disciplines like Mesothelioma, Adverse effect, Cisplatin and Intensive care medicine. The Clinical trial works featured in it incorporate elements from Head and neck cancer, Venetoclax, Ruxolitinib, Medical prescription and Cannabis. The concepts on Disease presented in it can also apply to other research fields, including Malignancy, Metastasectomy, Quality of life and Prostate cancer.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Current Treatment Options in Oncology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Current Treatment Options in Oncology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 5.45% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 32.69% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.69% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.42% of all publications and 45.19% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Although the typical journey of an author published in the Current Treatment Options in Oncology journal is largely documented in this article, information regarding the career pathways in the realm of Oncology, specifically the role of a Nurse Practitioner in Minnesota, is largely absent. A Nurse Practitioner is an advanced practice registered nurse classified as a mid-level practitioner. This role often provides primary care, but nurse practitioners can choose to specialize in fields like oncology and work directly with cancer patients. In Minnesota, becoming a Nurse Practitioner involves achieving a high level of education, passing a series of exams, and maintaining certain licensures and certifications. You can explore more detailed steps on how to become a nurse practitioner in Minnesota. Inclusion of such career insights in the field of Oncology could offer useful guidance for aspiring professionals who contribute to or rely on the research outlined in the Current Treatment Options in Oncology journal.
Melissa S Y Thong;Cornelis J F van Noorden;Karen Steindorf;Volker Arndt
(2020)Felicitas Thol;Arnold Ganser
(2020)Maran Ilanchezhian;Abhishek Jha;Karel Pacak;Jaydira Del Rivero
(2020)Jean Mathews;Breffni Hannon;Breffni Hannon;Camilla Zimmermann;Camilla Zimmermann
(2021)Suzanne Ryan;Joanne Wong;Ronald Chow;Camilla Zimmermann;Camilla Zimmermann
(2020)Briana R. Halle;Douglas B. Johnson
(2021)For those interested in Medicine in the USA, exploring related online degrees can open doors to diverse healthcare careers. Many students start their journey through an medical assistant to lpn bridge program online, which provides a streamlined path to becoming a licensed practical nurse while gaining hands-on experience.
Another foundational route is pursuing online biology degrees. Such programs equip students with critical scientific knowledge essential for medical school prerequisites or health science careers.
Nursing remains a crucial component of healthcare, and many opt for an online ASN degree to enter the field professionally. This flexible option is ideal for those balancing work, life, and education.
Additionally, an online degree in nutrition offers expertise in diet and wellness, complementing medical knowledge and opening pathways in public health and clinical nutrition roles.
